Deconex Tablet
Product Images NDC 50991-740

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Deconex (NDC 50991-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back (Dmxback)

Drug Facts panel for DECONEX DMX tablets including continued information on storage instructions, inactive ingredients, questions contact, and safety warnings. It lists active ingredients Dextromethorphan HBr 17.5 mg, Guaifenesin 400 mg, and Phenylephrine HCl 10 mg with purposes as cough suppressant and nasal decongestant. The panel details uses, warnings, dosage instructions for adults and children, and advises consulting a physician for children under 6.*

FDA Label Image

Label (Newdmx)

Label for DECONEX DMX tablets by Poly Pharmaceuticals, Inc., an oral human OTC drug. Each tablet contains 17.5 mg Dextromethorphan HBr, 400 mg Guaifenesin, and 10 mg Phenylephrine HCl. The label states the product is a cough suppressant, expectorant, and nasal decongestant. The package contains 100 tablets and includes a note about tamper evidence with a foil seal.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.